A melanoma subtype with intrinsic resistance to BRAF inhibition identified by receptor tyrosine kinases gene-driven classification.

Oncotarget · 2015 · PMC4467137 · PMID 25742786

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The same analysis was repeated for the Meta-Clinical dataset and the differential expression of 6 of the 7 RTKs was validated (FDR < 0.05, Supplementary Table 3 ), except for EPHA2 , which however showed a trend of differential expression (FDR = 0.052).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.